ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
ACT001-AU-002: A study to evaluate the safety and tolerability and pharmacokinetics of ACT001 in children with advanced brain and solid tumors
Protocol ID
ACT001-AU-002
Condition/s
Advanced brain tumour
Advanced solid tumour
Diagnosis Stage
Relapse/refractory
Location
NSW, WA
Sponsor
Accendatech AU Pty Ltd
CPR Pharma Services Pty Ltd
Trial Status
Closed to Recruitment
Sites
Perth Children's Hospital
Sydney Children's Hospital
Study Type
Treatment
Phase
Phase 1
Age Eligibility
1 Year to 21 Years
ANZCTR
ACTRN12618001934235
Back to Registry
Study Title ACT001-AU-002: A study to evaluate the safety and tolerability and pharmacokinetics of ACT001 in children with advanced brain and solid tumors
Protocol ID ACT001-AU-002
Disease (Sub Disease) Advanced brain tumour
Advanced solid tumour
Diagnosis Stage Relapse/refractory
Location NSW / WA
Sponsor Accendatech AU Pty Ltd / CPR Pharma Services Pty Ltd/
Links https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=376262&isReview=true
Trial Status Closed to Recruitment
Trial Open Date 18/09/2019
Sites Perth Children's Hospital / Sydney Children's Hospital/
Study Type Treatment
Phase Phase 1
Age Eligibility 1 Year to 21 Years
ANZCTR ACTRN12618001934235

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168